GlaxoSmithKline Research & Development Limited
Commercial
Also recorded in the register as: GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED. These spellings have been reviewed and merged onto this page — see data/organisation-aliases.json in the repository.
- Sector
- Companies
- Agreements as applicant
- 2
- In term in September 2026
- 0
- Distinct datasets
- 4
- Files released
- 56
- Latest agreement end date
- 17 October 2025
Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.
Agreements
| Agreement | Datasets | Files | Latest term | Status | Commercial |
|---|---|---|---|---|---|
| The Extended Salford Lung Study Data Access Project DARS-NIC-115298-L5X4V | 4 | 44 | 18 July 2024 to 17 October 2025 | Expired | Yes |
| INvestigation of TRELEGY Effectiveness: Usual PractIce Design (INTREPID) Exploratory data set DARS-NIC-297783-V4P6H | 4 | 12 | 31 August 2023 to 23 February 2025 | Expired | Yes |
Datasets named in its agreements
- Hospital Episode Statistics Accident and Emergency (HES A and E)
- Hospital Episode Statistics Admitted Patient Care (HES APC)
- Hospital Episode Statistics Critical Care (HES Critical Care)
- Hospital Episode Statistics Outpatients (HES OP)
Cite this page
NHS England (2026) Data Uses Register, September 2026 edition, agreements naming GlaxoSmithKline Research & Development Limited. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/organisations/glaxosmithkline-research-development-limited/ (accessed [date]).
This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.